OBJECTIVE: To investigate the usefulness of diffusion-weighted imaging (DWI)guided, single-voxel proton magnetic resonance spectroscopy (SVS) for preoperative evaluation of cerebral glioma grade. METHODS: For SVS, placement of volume-of-interest was guided by the minimal apparent diffusion coefficient value obtained from DWI. Spectral data for N-acetylaspartate (NAA), choline (Cho), and phosphocreatine (Cr) were analysed in 33 patients with primary gliomas. RESULTS: Cho/Cr and Cho/NAA ratios were significantly higher in high-grade than in low-grade gliomas; NAA/Cr ratios were significantly lower in high-grade than in low-grade gliomas. Receiver operating characteristic curve analysis demonstrated a threshold value of 2.01 for Cho/Cr for sensitivity, specificity, positive predictive and negative predictive values of 86.36%, 90.00%, 95.00% and 75.00%, respectively. Threshold values of 2.49 and 0.97 were obtained for Cho/NAA and NAA/Cr, respectively. Despite no significant difference in diagnostic accuracy between the metabolite ratios, diagnostic accuracy using the Cho/Cr ratio was slightly better than that of Cho/NAA or NAA/Cr. CONCLUSION: DWI-guided SVS has potential value for the preoperative prediction of glioma grade.
Introduction
In patients suspected of having cerebral glioma, noninvasive preoperative evaluation of brain tumour grade is important for treatment planning and prediction of prognosis. 1 Conventional magnetic resonance imaging (MRI) is considered to be a useful tool in grading brain tumours, but may lead to the misclassification of low-or high-grade tumours. 1 -7 Proton magnetic resonance spectroscopy ( 1 H-MRS), including single-and multivoxel spectroscopic imaging, has been used to grade cerebral gliomas. 2 -4 Multivoxel spectroscopic imaging methods are useful to identify glioma grade and allow selective evaluation of different parts of the target KEY WORDS: BRAIN; DIFFUSION-WEIGHTED IMAGING (DWI); CEREBRAL GLIOMA; IMAGE-GUIDED; MAGNETIC RESONANCE (MR); PROTON MR SPECTROSCOPY; TUMOUR GRADE a Z-L Liu and Q Zhou contributed equally to this article. Noninvasive evaluation of cerebral glioma by DWI-guided SVS volume. Unless spectral resolution is sacrificed, however, the acquisition time for this imaging method can be long. 8 Although single-voxel spectroscopy (SVS) is a reliable technique for analysis of tumour grade with a short acquisition time, the voxel placement is critical to the examination. To acquire 1 H-MRS from viable tumour tissue, researchers often place the voxel over an enhancing region of a contrast-enhanced MRI scan. 2 -4,9 Although contrast enhancement on conventional MRI signifies breakdown of the blood-brain barrier, it does not provide reliable information on tumour physiology, such as metabolism or cellularity, which is important for determining tumour grade. 10 Diffusion-weighted imaging (DWI) with quantitative apparent diffusion coefficient (ADC) calculation can provide information about microscopic motion of water protons, and is thought to be inversely correlated to tumour cellularity. 11 Its clinical use remains limited because of a considerable overlap in the ADC value between high-and lowgrade tumours. 12, 13 A significant difference has been reported, however, in the minimum ADC (ADC min ) values of the contrast-enhancing region of low-and high-grade gliomas. 14, 15 To date, no studies have investigated the use of localization of spectroscopy volumeof-interest (VOI), guided by the calculated ADC value of the tumour region, to grade gliomas. The present study determined whether magnetic resonance spectroscopic metabolite ratios obtained using DWIguided SVS were different between low-and high-grade gliomas, and investigated whether these were useful for predicting the grade of cerebral glioma.
Patients and methods

STUDY POPULATION
Patients with primary supratentorial gliomas who presented at Qilu Hospital of Shandong University, Jinan, China, between May 2006 and October 2010, were included in this retrospective study. Patients underwent MRI, DWI and SVS examinations and subsequent surgery for tumour removal. Histopathological specimens were obtained via surgical resection and graded according to World Health Organization (WHO) II criteria. 3,5 There were no other inclusion or exclusion criteria for the study.
Written informed consent was obtained from all patients after the nature of the examination had been fully explained. The study was approved by the Institutional Review Board of Qilu Hospital of Shandong University.
MRI AND 1 H-MRS
All examinations were performed on a 3.0-T MRI scanner (Signa ® EXCITE II; GE Medical Systems, Milwaukee, WI, USA). The conventional MRI consisted of axial T1weighted spin-echo (SE), T2-weighted fast SE, fluid-attenuated inversion-recovery (FLAIR) images and DWI. DWI was obtained using an axial echo-planar SE sequence (5000/64.9 ms repetition time/echo time [TR/TE]; 6-mm section thickness; diffusion gradient encoding in three orthogonal directions; diffusionsensitizing factor [b-value] = 1000 s/mm 2 ; 240 mm field of view; 160 × 192 matrix) in 1.00 min. Then, contrast-enhanced T1weighted SE images were obtained in axial, coronal and sagittal planes following intravenous administration of gadopentetate di meglumine (Magnevist ® ; Bayer Schering Pharma AG, Berlin, Germany) at a dose of 0.1 mmol/kg of body weight.
After DWI data acquisition, postprocessing of ADC maps was performed immediately using standard software (FuncTool 3.1 software; GE Medical Systems). ADC maps were generated with the software Noninvasive evaluation of cerebral glioma by DWI-guided SVS and were registered with contrast-enhanced axial T1-weighted images. On ADC maps, a region of interest (ROI) was placed manually on the solid area corresponding to the enhancing region of the lesion in each section. Each ROI measured between 225 and 400 mm 2 . The ADC value was automatically calculated using the software. Clinical observers were allowed to adjust the grey-scale window width and could centre the level settings to obtain the minimum ADC region; then, the region of minimal ADC value was marked on the DWI and contrast-enhanced axial T1-weighted images.
Finally, 1 H-MRS was performed by an independent investigator (Q.-S.Z.) after contrast-enhanced MRI. All 1 H-MRS studies were performed using the automated SVS package, Proton Brain Examination/Single Voxel (PROBE/SV; GE Medical Systems). SVS data were obtained using a point-resolved spectroscopy pulse sequence including water suppression, 1500/144 ms (TR/TE) and 96 averages. The acquisition time was 3 min. The VOI was placed on the marked region on the CE axial T1-weighted images. The voxel size ranged from 20 mm × 20 mm × 15 mm to 15 mm × 15 mm × 15 mm, based on the lesion volume.
Spectra were obtained using the standard software supplied by the manufacturer (FuncTool 3.1 software). They were subjectively considered to be good/excellent, satisfactory or poor, based on the degree of spectral baseline distortion, line width and numbers of resolved peaks observed. Metabolite peaks used were as follows: Nacetylaspartate (NAA) at 2.02 parts per million (ppm), choline (Cho) at 3.22 ppm, and phosphocreatine (Cr) at 3.01 ppm. Metabolite ratios (Cho/Cr, Cho/NAA and NAA/Cr) were also calculated using the above software.
STATISTICAL ANALYSES
Statistical analyses were performed using the SPSS ® software package, version 11.5 (SPSS Inc., Chicago, IL, USA) for Windows ® . The mean ± SD values of the ADC min and metabolite ratios (Cho/Cr, Cho/NAA and NAA/Cr) were calculated. Comparisons of the median metabolite ratios and ADC min values between low-and high-grade tumours were analysed using the Mann-Whitney U-test. A P-value of < 0.05 was considered to be statistically significant.
Receiver operating characteristic (ROC) curves were used to describe and compare the performance of the diagnostic values of the metabolite ratios. The aim was to assess the potential ability of DWI-guided SVS in the differentiation of low-grade and highgrade gliomas. High-grade tumours were considered as true positives; low-grade tumours were regarded as true negatives. The optimal cut-off value of the metabolite ratios was obtained from the ROC analysis.
Results
In total, 33 patients (20 males and 13 females; age range 19 -73 years; mean ± SD age 44.76 ± SD 13.09 years) with primary supratentorial gliomas were enrolled in the study. High-grade gliomas were detected in 23 patients (WHO II grade III, n = 8; WHO II grade IV, n = 15), and low-grade gliomas were detected in 10 patients (WHO II grade I, n = 4; WHO II grade II, n = 6).
In all 33 patients, the quality of the magnetic resonance spectra was classed as good/excellent in 25 cases, satisfactory in seven cases and poor in one case. Accordingly, 1 H-MRS data analyses with readily quantifiable Cho, Cr and NAA peaks were successfully performed in 32 of the 33 (96.97%) cases. In the remaining patient (diagnosed at WHO II grade IV with a haemorrhagic lesion), a substantial Noninvasive evaluation of cerebral glioma by DWI-guided SVS susceptibility artefact could not be overcome, despite attempts using multiple presaturation bands. Typical MRI and SVS data for two patients are shown in Figs 1 and 2. The ADC min values of high-and low-grade cerebral gliomas are summarized in Table 1 . A decrease in ADC min values from low-to high-grade gliomas was observed. The mean ADC min values were significantly higher in low-grade compared with high-grade gliomas (P = 0.016).
Ratios of metabolites according to tumour grade are shown in Table 2 . Cho/Cr and Cho/NAA ratios of the high-grade gliomas were both significantly higher than those of the low-grade gliomas (P = 0.001 and P = 0.003, respectively). NAA/Cr ratios of the high-grade gliomas were significantly lower than those of the low-grade gliomas (P = 0.049).
The diagnostic accuracy, sensitivity, specificity and positive and negative predictive values of metabolite ratios for predicting tumour grades were calculated using ROC analysis (Table 3 ). The area under the ROC curves revealed that each metabolite ratio proved to be powerful in differentiating high-grade from low-grade tumours. Although the overall diagnostic accuracy of the Cho/Cr ratio was slightly superior to that of either Cho/NAA or NAA/Cr ratios, this difference was not statistically significant between the metabolite ratios.
Discussion
It is important to differentiate high-grade from low-grade cerebral gliomas in order to establish an effective therapy. The current use of noninvasive, conventional MRI techniques can be helpful for predicting glial tumour grades preoperatively. 1 The use of DWI permits the topospecific identification of the histo pathological components of the glioma, and the ADC min values represent the cellularity of the solid tumour. 15, 16 Due to the advantages of DWI, in the present study DWI-guided SVS was performed on patients with cerebral gliomas. The major findings were as follows: (i) significant differences in the ADC min values and metabolite ratios were found between low-grade and high-grade gliomas, respectively; (ii) ROC curve analysis was used to calculate the cut-off values, and the resulting sensitivity, specificity and accuracy of DWI-guided SVS was obtained; and (iii) the diagnostic accuracy of the Cho/Cr ratio was slightly superior to that of the Cho/NAA or NAA/Cr ratios, although this finding was not statistically significant.
The ADC values of biological tissue reflect the Brownian movement of water molecules, thereby potentially revealing histopathological characteristics of cellular structure. 16, 17 As reported previously, DWI and the calculation of ADC values may aid conventional MRI in the characterization of cerebral tumours. 11 Other studies have used DWI and ADC values to grade gliomas and to differentiate between tumour types. 18, 19 These studies have, however, demonstrated conflicting results. A key reason might be the difference in the methods used for measuring ADC values. Rumboldt et al. 18 placed three 50 -100 mm 2 ROIs in the tumour region. The first ROI was placed over homogenous enhancing regions in the central portion of the tumour. Two additional ROIs were placed on homogeneous enhancing areas on different sections. A total of three lesion ROIs were obtained and averaged to serve as the tumour ADC value. In contrast, a second study placed a 10 -20 mm 2 ROI in the region of a solid tumour based on nonenhanced and enhanced MRI. 19 Several studies have assessed the role of the ADC min values to predict glioma grades. 14 -16 In these studies, ROI was carefully placed over the solid portion of the tumour to avoid volume averaging with cystic and/or necrotic areas that could influence the ADC value, and the Diagnostic accuracies of metabolite ratios in predicting tumour grade in patients with primary supratentorial gliomas (n = 32) in whom proton magnetic resonance spectroscopic data were available a Noninvasive evaluation of cerebral glioma by DWI-guided SVS ADC min value was selected for analysis. Consistent with the data presented here, these studies suggested that there were significant differences in the ADC min values between low-grade and high-grade gliomas. The feasibility of performing DWI-guided SVS in the evaluation of glioma grading was demonstrated in the present study. The diagnostic-quality spectra were obtained in 32/33 (96.97%) of patients with proper placement of saturation bands, prescanning and careful voxel placement. It should be noted, however, that all the lesions were located in the supratentorial cranial space. If the lesions had been located in the posterior fossa, spectral quality may have been poor, due to susceptibility artefacts.
Significant differences in the metabolite ratios between the groups of low-grade and high-grade gliomas were observed by DWIguided SVS, in accordance with previous studies. 3,4,9,20 -22 In contrast, another study demonstrated no significant differences in Cho/NAA ratios between low-grade and highgrade gliomas. 23 This may be due to differences in 1 H-MRS imaging techniques. Although SVS was performed with a 3.0-T scanner, the location of the voxel was adjusted to include the solid tumour portion, as determined by T2-weighted or FLAIR images. The T2-weighted or FLAIR images did not reflect tumour cell density or cell proliferative features. SVS was, however, guided by DWI in the present study. Regions with ADC min values reflect the sites of highest cellularity within heterogeneous tumours, therefore these sites may be of diagnostic value when identifying high-grade tumour components.
A ROC analysis was performed in the present study to determine potentially useful cut-off values of each metabolite ratio, and to differentiate high-grade from low-grade gliomas. Although these findings were similar to those reported elsewhere, 3,4,20 the actual threshold values for tumour grading varied between studies. A possible explanation for these variations could be differences in the 1 H-MRS imaging methods, including magnetic resonance field strength, acquisition parameters, voxel size and location. 24, 25 Alternatively, variations may occur due to the numbers of patients in the studies and the heterogeneity of glioma, especially glioblastoma multiforme. 23 Another study demonstrated that the NAA/Cr ratio was significantly lower in high-grade neoplasms (0.28) than in lowgrade neoplasms (0.69) (P < 0.0001) and that this difference was far greater than the difference in the Cho/Cr ratio. 26 The diagnostic accuracy of Cho/Cr ratios was slightly superior to that of the Cho/NAA or NAA/Cr ratios in the present study, although not statistically significant. The results are supported by other studies. 3,4,21,27,28 Shimizu et al. 28 investigated the correlation between choline levels measured by 1 H-MRS, and the Ki-67 labelling index (a measure of proliferation). A strong linear correlation between the Cho value and the Ki-67 index in gliomas was observed. 28 Thus, the increase in Cho metabolite levels correlated with the enhancement of cell turnover, which may correspond to the malignant regions of the tumour. This suggests that Cho-related metabolite ratios (Cho/Cr and Cho/NAA) might reflect the most malignant portion of the glioma. On the basis of another study 9 and the results presented here, the use of metabolite ratios, especially Cho/Cr ratios, could be a useful parameter for determining glioma grades.
In conclusion, in this study, DWI-guided SVS allowed the noninvasive differentiation of high-grade from low-grade gliomas, and potentially useful cut-off values for tumour grading were obtained using ROC curve analysis.
